Patents by Inventor Shigeki MORIGUCHI

Shigeki MORIGUCHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adamantylmethylamine derivative and use thereof as pharmaceutical
    Patent number: 11608313
    Abstract: The present invention provides a pharmaceutical composition for treating or preventing a cognitive disease or disorder, comprising a compound represented by Formula (I), an enantiomer thereof a diastereomer thereof, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: March 21, 2023
    Assignee: Tohoku University
    Inventors: Shigeki Moriguchi, Kohji Fukunaga, Yoshiharu Iwabuchi
  • ADAMANTYLMETHYLAMINE DERIVATIVE AND USE THEREOF AS PHARMACEUTICAL
    Publication number: 20200181066
    Abstract: The present invention provides a pharmaceutical composition for treating or preventing a cognitive disease or disorder, comprising a compound represented by Formula (I), an enantiomer thereof a diastereomer thereof, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 2, 2018
    Publication date: June 11, 2020
    Applicants: TOHOKU UNIVERSITY, Brain Innovation Co., Inc.
    Inventors: Shigeki MORIGUCHI, Koji FUKUNAGA, Yoshiharu IWABUCHI
  • Adamantane derivative and use thereof
    Patent number: 10487045
    Abstract: The present invention provides a pharmaceutical composition for treating or preventing a cognitive disease or disorder, containing a compound represented by Formula (I), an enantiomer thereof, a diastereomer thereof, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: November 26, 2019
    Assignees: Tohoku University, Brain Innovation Co., Inc.
    Inventors: Shigeki Moriguchi, Koji Fukunaga, Yoshiharu Iwabuchi
  • ADAMANTANE DERIVATIVE AND USE THEREOF
    Publication number: 20190055191
    Abstract: The present invention provides a pharmaceutical composition for treating or preventing a cognitive disease or disorder, containing a compound represented by Formula (I), an enantiomer thereof, a diastereomer thereof, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: January 26, 2017
    Publication date: February 21, 2019
    Applicant: TOHOKU UNIVERSITY
    Inventors: Shigeki MORIGUCHI, Koji FUKUNAGA, Yoshiharu IWABUCHI